Cargando…
Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
Selective serotonin reuptake inhibitors (SSRIs) are a class of drug widely used for treatment of mood disorders, including depression and cardiovascular disease. A search for related articles in the PubMed database was attempted. It covered studies, reports, reviews and editorials of the last 5 year...
Autores principales: | Wozniak, Greta, Toska, Aikaterini, Saridi, Maria, Mouzas, Odysseas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560505/ https://www.ncbi.nlm.nih.gov/pubmed/21873959 http://dx.doi.org/10.12659/MSM.881924 |
Ejemplares similares
-
Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Jannini, Tommaso B., et al.
Publicado: (2022) -
Selective serotonin reuptake inhibitors and violent crime: do SSRI’s kill or cure?
por: Sneep, S., et al.
Publicado: (2022) -
Review on Surface-Modified Electrodes for the Enhanced Electrochemical Detection of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Barry, Simone C. L., et al.
Publicado: (2023) -
Identifying knowledge gaps in understanding the effects of selective serotonin reuptake inhibitors (SSRIs) on fish behaviour
por: Ferreira, Carla S.S., et al.
Publicado: (2023) -
In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Yi, Julie, et al.
Publicado: (2022)